We expect the domestic plastic labware market expected to grow at a healthy rate of ~16% and players with quality products, wide distribution reliability and competitive pricing to outperform the sector, where Tarsons surpasses peers. The company’s in-house manufacturing capability provides a competitive edge. Moreover, Tarsons has a strong and well-diversified distribution network across India and a diversified product portfolio with 1,700+ SKUs across 300 products, which is difficult to replicate

Based on valuation correction and expected likelihood broadly unchanged guidance/commentary in 1QFY23. Our preferred pick to play IT stocks in near terms is Infosys (valuations corrected 26%, price by 18%) and TECHM (valuation down 38%, price – 32%) among large caps. Among mid-caps preferred picks are: LTI (valuation -49%, price – 42%) and LTTS (valuation -33%, price -23%). Under volatile/uncertain scenario, we prefer large caps or large mid-caps over small caps

Balance sheet strength continues along with capex announcements

The Shift: Changing business orientation

Gaining traction as pieces fall in place

Small is beautiful

Strong show across ports; port margin touches 70%

PNC’s strengths – stable NWC, low leverage and high RoCE

SUN PHARMA entering into an earnings upgrade cycle

Refuelling for next leg of growth